A new continuous glucose monitor (CGM) that is not only non-invasive but that predicts blood sugar levels from ECG data ...

XYRA LLC, a private biopharmaceutical company, is committed to developing innovative therapies for cardiac rhythm disorders with high unmet needs.  With the widespread use of FDA-approved wearable ...

Blessing Foundation donors purchased two LIFEPAK 15 Trainer Cardiac Monitors for students of Blessing Hospital’s Emergency ...

The global cardiac ambulatory monitoring market, valued at USD 13.3 billion in 2021, is set for substantial growth, with a ...

Every year, about 356,000 people in the U.S. suffer sudden cardiac arrest (SCA) outside of the hospital. Sudden cardiac arrest occurs when the heart suddenly stops beating, even in people ...

The Apple Watch has long been the Bad Bad Leroy Brown of smartwatches (baddest man in the whole damned town). The new Series ...

The CEO at the Illinois-based company with operations in Minnesota expects earning to return to a pre-pandemic profit model ...

With its pulsed-field ablation system approved in the EU and US, Boston Scientific aims to lead the pack in atrial ...

The Oxnard City Council will vote Tuesday on a resolution that urges St. John's Regional Medical Center to stop outsourcing ...

The medical devices industry is on the verge of an incoming boom, fueled by its growing demand and technological advancements ...

The cardiac ultrasound systems market is estimated to secure a valuation of USD 2.33 billion with a CAGR of 5% by 2033. In ...